drugset / Trial / NCT02568033

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

NCT02568033

Phase 0 Unknown 22 enrolled The Cooper Health System
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study looking at using stereotactic radiosurgery and full dose chemotherapy to treat stage II and III lung cancer that is not amendable to surgical resection.

Timeline

Start
2013-10
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule
Subject Cisplatin Other / unclassified 75 mg/m2
Subject Docetaxel Small molecule 75 mg/m2
Subject Paclitaxel Small molecule 75 mg/m2
Subject Paclitaxel Small molecule 200 mg/m2
Subject Pemetrexed Small molecule 500 mg/m2